A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein

Zika virus (ZIKV) infection poses a serious threat to human health. However, no licensed vaccine or therapeutic drug is currently available for ZIKV. We have previously shown that recombinant ZIKV E80 protein induced potent neutralizing antibody response and protected mice from lethal viral challeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Panke, Zhang, Chao, Li, Min, Ma, Weimin, Xiong, Pei, Liu, Qingwei, Zou, Gang, Lavillette, Dimitri, Yin, Feifei, Jin, Xia, Huang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997156/
https://www.ncbi.nlm.nih.gov/pubmed/32025335
http://dx.doi.org/10.1038/s41421-019-0140-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997156/
https://www.ncbi.nlm.nih.gov/pubmed/32025335
http://dx.doi.org/10.1038/s41421-019-0140-8

Ejemplares similares